Vemurafenib is a drug used to treat patients with skin melanoma that does not improve with other types of treatment or has metastases in other organs, has proven its effectiveness, even in cases of malignant cancers with metastasis, for its action on neutralizing the cell mutation.
To use this remedy, it is also necessary for the cancer to be caused by the BRAF V600 gene mutation, because it is this mutation that the drug is able to prevent, which decreases the degree of development of the cancer. , a blood test is necessary to confirm the change before starting treatment.
Vemurafenib is produced by Roche Pharma laboratories under the trade name Zelboraf in boxes of 240 mg tablets.
The price of Vemurafenib varies by place of purchase, but costs an average of 8,000 reais for each box of 56 tablets.
This drug is indicated for the treatment of melanomas positive to the braF V600 mutation, metastatic or difficult to treat.
Treatment of any type of cancer should be guided by an oncologist, depending on the evolution of the disease and the patient’s history; However, in most cases, Vemurafenib is treated with 4 240 mg tablets, twice daily, until your doctor tells you to. .
The main side effects of this remedy include decreased appetite, headache, constant cough, diarrhea, vomiting, nausea, constipation, joint pain, excessive fatigue and muscle pain.
Vemurafenib is contraindicated in patients with hypersensitivity to the active ingredient or one of the components of the drug.
Learn about all the options available for treating skin cancer.